LifeScan Global Corporation
Case Number:
4:25-bk-90259
Court:
Nature of Suit:
Firms
- Carrington Coleman
- Chamberlain Hrdlicka
- Chiesa Shahinian
- Diamond McCarthy
- Eversheds Sutherland
- Foley & Lardner
- Fox Rothschild
- Greenberg Traurig
- Haynes Boone
- Hellring Lindeman
- Hogan Lovells
- Husch Blackwell
- Jackson Walker LLP
- Kelley Drye
- Klehr Harrison
- Nixon Peabody
- Norton Rose
- Pachulski Stang
- Patterson Belknap
- Paul Hastings
- Porter Hedges
- Preti Flaherty
- Reed Smith
- Shipman & Goodwin
- Vartabedian Hester
- White and Williams
- Womble Bond
Companies
- Ankura Consulting Group LLC
- Bank of America Corp.
- Cardinal Health Inc.
- Cencora Inc.
- Change Healthcare Inc.
- CVS Health Corp.
- Express Scripts Holding Co.
- Facet Technologies LLC
- Flex Ltd.
- Google LLC
- Horizon Blue Cross Blue Shield of New Jersey
- Independent Health Association Inc.
- Jefferies Financial Group Inc.
- LifeScan Inc.
- McKesson Corp.
- Optum Inc.
- OptumRx Inc.
- Oracle Corp.
- Prime Therapeutics LLC
- Province LLC
- Salesforce.com Inc.
- The Cigna Group
- Zinc Health Services LLC
Government Agencies
Sectors & Industries:
-
July 18, 2025
Meet The Attorneys Guiding LifeScan's Ch. 11
A team of lawyers from Milbank LLP and Porter Hedges LLP is overseeing the Chapter 11 bankruptcy of LifeScan Global Corp., a blood glucose monitoring device maker, as it seeks to reduce debt through a restructuring plan set for confirmation in September.
-
July 16, 2025
Glucose Monitoring Co. LifeScan Hits Ch. 11 With $1.7B Debt
LifeScan Global Corp., a company that makes blood glucose monitoring devices, has filed for Chapter 11 protection in Texas bankruptcy court with $1.7 billion of debt and a plan supported by its private equity backer to trim more than 75% of debt by handing the business to existing lenders.
- ← Previous
- 1
- 2
- Next →